NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Duke Street Bio

Duke Street Bio

Private
LondonHealthcare & Life Scienceshttps://dukestbio.com/

Last Round

Seed Round

Jun 11, 2026

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Duke Street Bio is a biotechnology company that develops precision medicine-based cancer therapies targeting DNA damage repair deficiencies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

precision medicineDNA damage repairDDRPARP inhibitoroncology biotechsmall molecule therapyhomologous recombination deficiencyHRDsolid tumor treatmentdrug discoveryclinical stage biotechcancer drug pipelinebiotech startupdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Duke Street Bio Comparables

Compare Duke Street Bio with similar companies based on industry and business-model similarity.

Duke Street Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Synnovation Therapeutics
91%
Tilikum Therapeutics
90%
Idience Co., Ltd.
86%

Duke Street Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 11, 2026
Seed RoundJan 17, 2024
VC RoundMay 22, 2022

Key People

Founding team and executive leadership

Barry McGuinness

Chief Operating Officer And Co-Founder

Founding Team

Phill Cowley

Chief Scientific Officer And Co-Founder

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 11, 2026

    Raised $4.1M in a seed funding round.

  • Jan 17, 2024

    Raised $2.5M in Seed funding.

Duke Street Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Duke Street Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Duke Street Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range10
Year Founded2020
Last FundingJun 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.